HYUNDAI BIOLAND Co.,Ltd.

Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.

052260 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장, 청주시
Website:: https://www.hyundaibiolandmedical.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HYUNDAI BIOLAND Co., Ltd. is a comprehensive healthcare and biotechnology company specializing in the research, development, and manufacturing of biomaterials derived from natural resources. The company's core business operates across three main sectors: cosmetics, nutraceuticals (health supplements), and regenerative medicine. It is a key supplier of raw materials, including collagen and hyaluronic acid, to the cosmetics industry. In the nutraceuticals field, it provides functional ingredients for health foods. For the biomedical market, the company develops medical devices such as resorbable membranes for dental and periodontal tissue regeneration. Leveraging its position as a leading natural materials company in Korea, Hyundai Bioland distributes its products to over 35 countries, with safety certifications in 33 nations.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HYUNDAI BIOLAND Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-29 00:00	Regulatory News Service 대규모기업집단현황공시[분기별공시(개별회사용)]	Korean	7.7 KB
2025-08-26 00:00	Report Publication Announcement 기업설명회(IR)개최	Korean	6.7 KB

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOLAND Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HYUNDAI BIOLAND Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Lytix Biopharma AS Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.	Norway	LYTIX
MaaT Pharma Developing gut microbiome therapies to improve survival for cancer patients.	France	MAAT
Mabion S.A. Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.	Poland	MAB
Magle Chemoswed Holding AB A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.	Sweden	MAGLE
Mainz BioMed N.V. Develops at-home diagnostic tests for the early detection of life-threatening cancers.	Germany	N/A
Marinomed Biotech AG Develops virus-blocking products & immunology therapies via proprietary technology platforms.	Austria	MARI
Matricelf Ltd. Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.	Israel	MTLF
Median Diagnostics Inc. Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.	South Korea	233250
MediciNova,Inc. Developing small-molecule drugs for neurology, respiratory, and liver diseases.	Japan	4875
Medicon Hellas S.A. Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.	Greece	MEDIC